Biomonitoring will become more and more common as we move forward.  The feasibility of us interacting with our electronic environment via biosensors will allow more personalized interactions.  We already see personalized interactions with:

1. Websites that track our preferences and suggest information that is related to these preferences.

2. Pacemakers and defibrillators that can adjust pacing rates based upon activity and breathing.

3. Glucose monitors that automatically adjust insulin dosing based upon blood glucose levels.

Ford is investigating the use of leadless ECG monitoring system in the driver’s seat.  Though it is investigational, one can see the possibility of tracking a driver’s heart for use in several ways such as monitoring for stress response prior to accident, ischemia, bradycardia (or heart block), and arrhythmias (such as atrial fibrillation).  Interesting to think about the implications of this data and privacy issues.

See link below for more information:

http://medgadget.com/2011/05/ford-unveils-contactless-ecg-sensing-driver-seat.html